Hy-Line

Founded in 1963, Hy-Line International is a prominent entity within the agriculture and livestock sectors, specializing in the provision of genetically modified egg-laying chickens. The company's core operations revolve around breeding and poultry, serving the global poultry industry with advanced genetic stock. With a history spanning over six decades, Hy-Line has established itself as a key player in animal genetics and breeding technology, contributing significantly to the efficiency and productivity of commercial egg production worldwide. Its commitment to research and development ensures continuous improvement in bird performance, health, and sustainability.

Hy-Line International operates with a substantial workforce, ranging between 500 and 1,000 employees, and maintains a presence across 6 distinct locations. This operational footprint supports its extensive breeding programs and distribution networks. The company's product offerings are centered on high-quality breeding stock, designed to meet the diverse needs of poultry producers. Understanding the importance of its human capital, the company allows for insights into its organizational structure and leadership through Meet Hy-Line's team. This focus on team expertise underpins its ability to deliver innovative solutions and maintain its leadership position in the market.

The company generates significant revenue, reported at $100.0M, reflecting its scale and market penetration. Hy-Line International competes in a dynamic market against major players such as Aviagen, Cobb, and Rose Acre Farms, among others. Its strategic focus on genetic advancement and customer support allows it to maintain a competitive edge. The company's headquarters are situated in West Des Moines, Iowa, serving as the central hub for its global operationsView more...